This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Management

Authoring team

  • accurate assessment of the size of the effusion and, where necessary, loculations using ultrasound or CT scanning
  • early diagnostic pleural aspiration, to assess fluid appearance, bacteriology and biochemistry
  • antibiotic therapy - depends on the bacteriology of the aspirated fluid; often requires metronidazole because organisms may not be revealed by culture
  • pleural fluid is drained - if this is not possible then surgery is indicated (surgical evacuation and lung decortication so that it may be fully expanded and so obliterate the pleural space)
  • intrapleural fibrinolytic therapy - a systematic review stated " with complicated infective pleural effusion or empyema, intrapleural fibrinolytic therapy was associated with a reduction in the requirement for surgical intervention and overall treatment failure but with no evidence of change in mortality" (2)
  • consider the possibility of tuberculosis

Reference:

  1. Drug and Therapeutics Bulletin 2006; 44 (3): 17-20.
  2. Altmann ES et al. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema. Cochrane Systematic Review October 2019

 


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.